Normalized to the time point of tumor implantation (0 h), MCT4 gliomas showed an increase in tumor growth after 48 h, whereas the tumor size of MCT4KD and inhibitor-treated MCT4 gliomas decreased (Figures 5(a) and 5(b)). The gene discussed is SLC16A3; the disease is central nervous system cancer.